Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,591
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Halifax, Boston MA, Hamden CT, Quebec, Sherbrooke,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase 2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Providence RI, New Haven CT, Lake Success NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New York NY, Newark NJ, Livingston NJ, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
Rural Illinois Lung Cancer Screening Initiative
for
Lung Cancer
Location: Springfield IL
Sponsor: Southern Illinois University
Sex: All
Age: 50 - 70+
Code: NCT06084078
Recruiting
Vasoactive Drugs in Intensive Care Unit
for
Shock
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT02118467
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: New Brunswick NJ, Florham Park NJ, Tampa FL, Canton OH,
Sponsor: Oncolytics Biotech
Sex: All
Age: 18+
Code: NCT07446322
Phase 2, Recruiting
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
for
Hepatitis C
Location: Stony Brook NY, The Bronx NY, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: Female
Age: 16 - 45
Code: NCT07040319
Phase 1, Phase 2, Recruiting
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
for
Prostate Cancer
Location: Hampton VA, Warrenville IL, Oklahoma City OK,
Sponsor: Proton Collaborative Group
Sex: Male
Age: 18+
Code: NCT01492972
Phase 3, Recruiting
Physica System Total Knee Replacement Registry Study
Location: New York NY, Lake Success NY, New Brunswick NJ,
Sponsor: Generate Biomedicines
Sex: All
Age: 18+
Code: NCT07484022
Phase 1, Recruiting
NeuroVision vs Standard Neuromonitoring
for
Neurologic Deficits
Location: Chicago IL
Sponsor: Rush University Medical Center
Sex: All
Age: 0+
Code: NCT04639297
Recruiting
Effect of Early Parent Education on Children's Sleep
for
Sleep
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 0+
Code: NCT07515534
Recruiting
Endotype DIrected Treatment for OSA in Down Syndrome
for
Obstructive Sleep Apnea (OSA), Down Syndrome
Location: Philadelphia PA, Miami FL, Park Ridge IL, Tucson AZ,
Sponsor: University of Arizona
Sex: All
Age: 6+
Code: NCT07280468
Recruiting
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
for
Mesothelioma
Location: New York NY, Chicago IL
Sponsor: Taxolog Inc.
Sex: All
Age: 18+
Code: NCT00685204
Phase 2, Recruiting
Mobilizing Community Hypertension Access Pilot
for
Hypertension
Location: Chicago IL
Sponsor: Rush University Medical Center
Sex: All
Age: 18+
Code: NCT07547345
Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Charlottesville VA, Winston-Salem NC, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06015880
Phase 1, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Quebec, Westbury NY, New York NY, Montreal, Norfolk VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,